2C-T-9, also known as 4-tert-butylthio-2,5-dimethoxyphenethylamine, is a psychedelic drug of the phenethylamine and 2C families. It is taken orally.
Use and effects According to Alexander Shulgin in his book PiHKAL (Phenethylamines I Have Known and Loved), the dose range of 2C-T-9 is 60 to 100mg orally and its duration is 12 to 18hours. Its effects included impairment such that one would not feel comfortable to drive, more effects "to the body than to the head", "body energy", sleeping difficulties, and hangover. The drug did not produce psychedelic visuals. One of the reports of 2C-T-9 was rated as a "plus-three" on the Shulgin Rating Scale.
Interactions
Pharmacology Pharmacodynamics 2C-T-9 has been found to act as a serotonin 5-HT2A receptor agonist with modest potency ( = 150nM). The drug failed to produce the head-twitch response, a behavioral proxy of psychedelic effects, in rodents at the assessed dose of 3mg/kg, which was said to parallel its known low potency in humans.
Chemistry Synthesis The chemical synthesis of 2C-T-9 has been described.
History 2C-T-9 was first described in the scientific literature by Alexander Shulgin and colleagues in 1991. This included in a journal article and in his book PiHKAL (Phenethylamines I Have Known and Loved).
Society and culture Legal status Canada 2C-T-9 is a controlled substance in Canada under phenethylamine blanket-ban language.
See also Substituted methoxyphenethylamine 2C (psychedelics)
References
External links 2C-T-9 - Isomer Design 2C-T-9 - PiHKAL - Isomer Design 2C-T-9 - PiHKAL - Erowid